Angela Cenci Nilsson
51 – 100 of 155
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2015
-
Mark
Increased CSF biomarkers of angiogenesis in Parkinson disease.
(
- Contribution to journal › Article
-
Mark
Pharmacological stimulation of metabotropic glutamate receptor type 4 in a rat model of Parkinson's disease and l-DOPA-induced dyskinesia: Comparison between a positive allosteric modulator and an orthosteric agonist.
(
- Contribution to journal › Article
- 2014
-
Mark
Cell type-specific plasticity of striatal projection neurons in parkinsonism and L-DOPA-induced dyskinesia.
(
- Contribution to journal › Article
-
Mark
Presynaptic Mechanisms of l-DOPA-Induced Dyskinesia: The Findings, the Debate, and the Therapeutic Implications.
(
- Contribution to journal › Scientific review
-
Mark
Mechanisms of Dopamine D1 Receptor-Mediated ERK1/2 Activation in the Parkinsonian Striatum and Their Modulation by Metabotropic Glutamate Receptor Type 5.
2014) In The Journal of Neuroscience : the official journal of the Society for Neuroscience 34(13). p.4728-4740(
- Contribution to journal › Article
-
Mark
Pharmacological stimulation of sigma-1 receptors has neurorestorative effects in experimental parkinsonism.
(
- Contribution to journal › Article
-
Mark
Glutamatergic pathways as a target for the treatment of dyskinesias in Parkinson's disease.
(
- Contribution to journal › Article
-
Mark
Molecular adaptations of striatal spiny projection neurons during levodopa-induced dyskinesia
2014) In Proceedings of the National Academy of Sciences of the United States of America 111(12). p.4578-4583(
- Contribution to journal › Article
-
Mark
Preclinical models of levodopa-induced dyskinesia
2014) p.335-353(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Investigating the molecular mechanisms of L-DOPA-induced dyskinesia in the mouse
(
- Contribution to journal › Article
-
Mark
Chapter 22 - Rodent Models of Treatment-Related Complications in Parkinson Disease
2014) p.373-386(
- Chapter in Book/Report/Conference proceeding › Book chapter
- 2013
-
Mark
Bad News for Neuroprotective Therapies in PD?
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Region-specific restoration of striatal synaptic plasticity by dopamine grafts in experimental parkinsonism.
(
- Contribution to journal › Article
-
Mark
Modulating mGluR5 and 5-HT1A/1B receptors to treat l-DOPA-induced dyskinesia: Effects of combined treatment and possible mechanisms of action.
(
- Contribution to journal › Article
- 2012
-
Mark
Levodopa-induced dyskinesia is strongly associated with resonant cortical oscillations.
2012) In The Journal of Neuroscience : the official journal of the Society for Neuroscience 32(47). p.16541-16551(
- Contribution to journal › Article
-
Mark
Glutamatergic mechanisms in the dyskinesias induced by pharmacological dopamine replacement and deep brain stimulation for the treatment of Parkinson's disease
(
- Contribution to journal › Scientific review
-
Mark
A Model of GDNF Gene Therapy in Mice with 6-Hydroxydopamine Lesions: Time Course of Neurorestorative Effects and ERK1/2 Activation
(
- Contribution to journal › Article
-
Mark
In vivo evidence for a differential contribution of striatal and nigral D1 and D2 receptors to l-DOPA induced dyskinesia and the accompanying surge of nigral amino acid levels
(
- Contribution to journal › Article
-
Mark
Impact of L-DOPA treatment on regional cerebral blood flow and metabolism in the basal ganglia in a rat model of Parkinson's disease.
(
- Contribution to journal › Article
- 2011
-
Mark
The locus coeruleus Is Directly Implicated in L-DOPA-Induced Dyskinesia in Parkinsonian Rats: An Electrophysiological and Behavioural Study
(
- Contribution to journal › Article
-
Mark
Parkinson disease: Poor results for retinal cell transplants in Parkinson disease.
(
- Contribution to journal › Article
-
Mark
Impact of the lesion procedure on the profiles of motor impairment and molecular responsiveness to L-DOPA in the 6-hydroxydopamine mouse model of Parkinson's disease.
(
- Contribution to journal › Article
-
Mark
Putaminal Upregulation of FosB/Delta FosB-Like Immunoreactivity in Parkinson's Disease Patients with Dyskinesia
(
- Contribution to journal › Article
-
Mark
Current Options and Future Possibilities for the Treatment of Dyskinesia and Motor Fluctuations in Parkinson's Disease
(
- Contribution to journal › Article
-
Mark
Vascular endothelial growth factor is upregulated by L-dopa in the parkinsonian brain: implications for the development of dyskinesia.
(
- Contribution to journal › Article
-
Mark
Apoptosis-inducing factor mediates dopaminergic cell death in response to lps-induced inflammatory stimulus Evidence in Parkinson's disease patients.
(
- Contribution to journal › Article
-
Mark
In vivo microdialysis studies of striatal dopamine efflux and its relationship to L-DOPA-induced dyskinesia in mouse models of Parkinson's disease.
2011) 41st Annual Meeting of the Society-for-Neuroscience(
- Contribution to conference › Abstract
-
Mark
Mechanisms underlying cortical resonance in levodopa-induced dyskinesia
2011) Annual Meeting of Society for Neuroscience 2011(Neuroscience 2011)(
- Contribution to conference › Abstract
-
Mark
Cortical resonance around 80 Hz is linked to dyskinesia after levodopa treatment in a rodent model of Parkinson’s disease
2011) Annual Meeting of Society for Neuroscience 2011(Neuroscience 2011)(
- Contribution to conference › Abstract
- 2010
-
Mark
Calcium-permeable AMPA receptors are involved in the induction and expression of l-DOPA-induced dyskinesia in Parkinson's disease
(
- Contribution to journal › Article
-
Mark
Recent Advances In Parkinson'S Disease: Translational And Clinical Research Preface
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Deuterium substitutions in the L-DOPA molecule improve its anti-akinetic potency without increasing dyskinesias
(
- Contribution to journal › Article
-
Mark
Immunohistochemical Detection of Fosb/Delta fosb-Like Proteins Maps Areas of Maladaptive Neuroplasticity in the Post-Mortem Parkinsonian Brain
(
- Contribution to journal › Published meeting abstract
-
Mark
Post- Versus Pre-Synaptic Plasticity
(
- Contribution to journal › Published meeting abstract
-
Mark
Maladaptive striatal plasticity in L-DOPA-induced dyskinesia.
(
- Contribution to journal › Scientific review
-
Mark
Maladaptive plasticity of serotonin axon terminals in levodopa-induced dyskinesia.
(
- Contribution to journal › Article
-
Mark
L-DOPA-induced dopamine efflux in the striatum and the substantia nigra in a rat model of Parkinson's disease: temporal and quantitative relationship to the expression of dyskinesia.
(
- Contribution to journal › Article
-
Mark
A mGluR5 antagonist under clinical development improves L-DOPA-induced dyskinesia in parkinsonian rats and monkeys.
(
- Contribution to journal › Article
-
Mark
Inhibition of Ras-guanine nucleotide-releasing factor 1 (Ras-GRF1) signaling in the striatum reverts motor symptoms associated with L-dopa-induced dyskinesia.
(
- Contribution to journal › Article
-
Mark
Dyskinesia - Advances in the understanding of pathophysiology and possible treatment options
(
- Contribution to journal › Article
-
Mark
6-OH Dopamine Rat Model
2010) p.3-5(
- Chapter in Book/Report/Conference proceeding › Entry for encyclopaedia/dictionary
-
Mark
Climbing behaviour
2010) p.26-27(
- Chapter in Book/Report/Conference proceeding › Entry for encyclopaedia/dictionary
-
Mark
Tail-pinch stimulus
2010) p.209-210(
- Chapter in Book/Report/Conference proceeding › Entry for encyclopaedia/dictionary
-
Mark
Recent advances in Parkinson's disease : basic research. Preface
(
- Contribution to journal › Article
-
Mark
Preface
(
- Chapter in Book/Report/Conference proceeding › Foreword/Postscript
-
Mark
Differential molecular and behavioural response to L-DOPA in mice injected with 6-hydroxydopamine in the striatum or in the medial forebrain bundle
2010)(
- Contribution to conference › Poster
- 2009
-
Mark
Antagonizing L-type Ca2+ Channel Reduces Development of Abnormal Involuntary Movement in the Rat Model of L-3,4-Dihydroxyphenylalanine-Induced Dyskinesia
(
- Contribution to journal › Article
-
Mark
Pharmacological modulation of glutamate transmission in a rat model of L-DOPA-induced dyskinesia: effects on motor behavior and striatal nuclear signalling.
(
- Contribution to journal › Article
-
Mark
Chronic intermittent L-DOPA treatment induces changes in dopamine release
(
- Contribution to journal › Article
-
Mark
Differential Involvement of D1 and D2 Dopamine Receptors in L-DOPA-Induced Angiogenic Activity in a Rat Model of Parkinson's Disease.
(
- Contribution to journal › Article